Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC38
TNBC
Basal B
AG1024
IGF1R
RTK
7469.066
uM
inf
inf
0.9727 0.9727 0.0000 0.0128
-0.0529
2.0057
21MT-1
HER2amp
-
Disulfiram
Proteasome
Proteasome
13719.174
uM
inf
0.02944
0.8637 0.8697 4.9974 0.0852
0.6419
0.8124
BT-20
TNBC
Basal A
Ro 32-0432
PKC
PKC
10581.142
uM
inf
inf
1.0451 1.0451 0.0000 0.0021
-0.0023
0.7885
Hs 578T
TNBC
Basal B
PS-1145
IKK
NFKB
10379.065
uM
inf
342.78730
0.7651 0.7643 3.2459 0.0223
0.9146
2.2436
HCC1954
HER2amp
Basal A
GSK1838705A
IGF1R
RTK
7457.09
uM
inf
inf
0.9111 0.9111 0.0000 0.0435
0.5105
1.7392
HCC1395
TNBC
Basal B
Epirubicin
TOP2
TOP
7816.017
uM
inf
inf
0.6386 0.6386 0.0000 0.2394
0.3980
1.2318
SUM225CWN
HER2amp
Basal A
Temsirolimus
MTOR
MTOR
10579.144
uM
inf
inf
-0.9866 -0.9866 0.0000 0.8900
0.5669
0.9576
BT-474
HER2amp
Luminal
AS-252424
PI3K
PI3K
12178.158
uM
inf
inf
0.0271 0.0271 0.0000 0.1623
0.5062
0.7379
HCC1806
TNBC
Basal A
GSK1838705A
IGF1R
RTK
7450.098
uM
inf
6.96490
0.8269 0.8202 1.2453 0.0172
0.8654
2.2139
HCC1395
TNBC
Basal B
Erlotinib
EGFR
ErbB
7436.091
uM
inf
17.23990
0.5816 0.5613 2.2376 0.0241
0.9542
1.2489
BT-474
HER2amp
Luminal
XRP44X
ELK3
MAPK
12056.157
uM
inf
0.25218
0.6336 0.6521 1.1164 0.2064
0.5892
0.9748
Hs 578T
TNBC
Basal B
PD 98059
MEK
MAPK
10694.152
uM
inf
inf
0.8155 0.8155 0.0000 0.0947
0.0324
2.4238
AU565
HER2amp
Luminal
GW-5074
CRAF
MAPK
5900.088
uM
inf
7.75810
0.6475 0.6473 4.9899 0.0383
0.9887
2.7830
MDA-MB-231
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7893.016
uM
inf
19.83710
0.9104 0.9100 4.9988 -0.0081
0.6344
2.2064
Hs 578T
TNBC
Basal B
AG1024
IGF1R
RTK
7473.066
uM
inf
inf
1.0500 1.0500 0.0000 -0.0434
-6.5378
2.3582
HCC2185
TNBC
Luminal
PS-1145
IKK
NFKB
7462.065
uM
inf
12.12690
0.5787 0.6650 4.9993 0.1530
0.7936
0.3950
MDA-MB-157
TNBC
Basal B
Nilotinib
ABL
nRTK
12594.17
uM
inf
inf
0.8144 0.8144 0.0000 0.0415
0.5417
1.2180
HCC1395
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
12000.167
uM
inf
inf
0.7814 0.7814 0.0000 0.1511
-0.0746
0.7185
HCC1395
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
12084.154
uM
inf
inf
0.7715 0.7715 0.0000 0.1395
-0.0309
1.2963
BT-474
HER2amp
Luminal
ZM-447439
AURK
AURK
12178.16
uM
inf
inf
0.5577 0.5577 0.0000 0.3142
0.4077
0.7392
SUM225CWN
HER2amp
Basal A
XRP44X
ELK3
MAPK
12098.157
uM
inf
1.40390
0.3594 0.5068 4.9916 0.1832
0.8708
1.3067
MDA-MB-175-VII
HR+
Luminal
Cetuximab
EGFR
ErbB
7885.042
uM
inf
inf
1.0037 1.0037 0.0000 0.0264
0.1320
0.5912
SUM225CWN
HER2amp
Basal A
ZM-447439
AURK
AURK
10579.138
uM
inf
inf
0.2201 0.2201 0.0000 0.2647
0.4560
0.9860
21MT-1
HER2amp
-
MG-132
Proteasome
Proteasome
14191.189
uM
inf
inf
-0.1161 -0.1161 0.0000 0.5482
0.5418
2.9704
MDA-MB-134-VI
HR+
Luminal
SB-3CT
MMP2/9
MMP
10998.144
uM
inf
inf
0.8777 0.8777 0.0000 0.0210
0.4718
0.8153